Loading...
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Subcutaneous MYL1501D insulin glargine 100 U/mL (hereafter referred to as MYL1501D insulin glargine) [Semglee(®)] is a long-acting human insulin analogue approved as a biosimilar of insulin glargine 100 U/mL (hereafter referred to as reference insulin glargine 100 U/mL) [Lantus(®)] in various countr...
Na minha lista:
| Udgivet i: | BioDrugs |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7217807/ https://ncbi.nlm.nih.gov/pubmed/32215829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-020-00418-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|